Article citationsMore>>

J. Stehlik, L. B. Edwards, A. Y. Kucheryavaya, P. Aurora, J. D. Christie, R. Kirk, et al., “The Registry of the International Society for Heart and Lung Transplantation: Twenty-Seventh Official Adult Heart Transplant Report—2010,” The Journal of Heart and Lung Transplantation, Vol. 29, No. 10, 2010, pp. 1089-1103. doi:10.1016/j.healun.2010.08.007

has been cited by the following article:

• TITLE: Short-Term Outcomes in Heart Transplant Recipients Treated with Generic Tacrolimus Compared to Prograf

  AUTHORS: Vinayak Dhungel, Monica M. Colvin-Adams, Peter M. Eckman

  KEYWORDS: Generic Tacrolimus; Heart Transplant

  JOURNAL NAME: Open Journal of Organ Transplant Surgery, Vol.3 No.2, May 15, 2013

  ABSTRACT: Calcineurin inhibitors are the cornerstone of solid organ transplant immunosuppression. Tacrolimus has only recently become available in a non-branded formulation, and there is little data on the efficacy and safety of generic tacrolimus, particularly following heart transplant. We performed a retrospective analysis of 21 consecutive patients who were treated with generic tacrolimus following heart transplant and compared rate of biopsy-proven acute cellular rejection to historical controls who were treated with Prograf. No significant difference in biopsy-proven acute cellular rejection was noted between the groups and rates of opportunistic infection and death were comparable. Although limited by the single-center, retrospective design, this preliminary data may be useful to clinicians facing the option of initiating generic tacrolimus following heart transplant.